Discussion
Targeting enzymes that control how cells process fatty molecules called sphingolipids may offer a promising new treatment strategy for Friedreich’s ataxia (FA), a study in cells and mice has found. Researchers discovered that enzymes involved in sphingolipid metabolism were disrupted in several cellular models of the disease. Targeting two…
